Disease | myelodysplastic syndrome |
Phenotype | C0007113|rectal cancer |
Sentences | 1 |
PubMedID- 26119923 | Purpose: to determine the relationship between the receipt of colony-stimulating factors (csfs) with erythropoiesis-stimulating agents (esas) and the risk of developing venous thromboembolism (vte), stroke, heart disease, and myelodysplastic syndrome (mds) in patients with colorectal cancer. |
Page: 1